- Report
- May 2024
- 130 Pages
Global
From €2725EUR$2,999USD£2,342GBP
€3634EUR$3,999USD£3,123GBP
- Report
- May 2024
- 133 Pages
Global
From €2725EUR$2,999USD£2,342GBP
€3634EUR$3,999USD£3,123GBP
- Report
- May 2024
- 129 Pages
Global
From €2725EUR$2,999USD£2,342GBP
€3634EUR$3,999USD£3,123GBP
- Report
- May 2024
- 131 Pages
Global
From €2725EUR$2,999USD£2,342GBP
€3634EUR$3,999USD£3,123GBP
- Report
- December 2022
- 153 Pages
Global
From €2385EUR$2,625USD£2,050GBP
€4770EUR$5,250USD£4,100GBP
- Report
- November 2022
- 286 Pages
Global
From €2385EUR$2,625USD£2,050GBP
€4770EUR$5,250USD£4,100GBP
- Report
- March 2022
- 273 Pages
Global
From €2385EUR$2,625USD£2,050GBP
€4770EUR$5,250USD£4,100GBP
- Report
- January 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,241GBP
- Report
- May 2025
- 226 Pages
Global
From €2272EUR$2,500USD£1,952GBP
- Report
- January 2023
- 165 Pages
Global
From €2272EUR$2,500USD£1,952GBP
- Report
- August 2025
- 175 Pages
Global
From €4089EUR$4,500USD£3,514GBP
- Report
- August 2025
- 100 Pages
Middle East
From €4498EUR$4,950USD£3,866GBP
- Report
- March 2023
- 150 Pages
Global
From €5406EUR$5,950USD£4,647GBP
- Report
- February 2025
- 85 Pages
India
From €3180EUR$3,500USD£2,733GBP
From €3180EUR$3,500USD£2,733GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3180EUR$3,500USD£2,733GBP
- Report
- September 2024
- 82 Pages
Japan
From €3180EUR$3,500USD£2,733GBP
- Report
- August 2024
- 130 Pages
North America
From €3635EUR$4,000USD£3,124GBP
- Report
- August 2025
- 186 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,076GBP
- Report
- January 2025
- 180 Pages
Global
From €4089EUR$4,500USD£3,514GBP

Lung cancer is a type of cancer that originates in the lungs. It is the leading cause of cancer-related death worldwide. Oncology is the branch of medicine that deals with the diagnosis, treatment, and prevention of cancer. Lung cancer is one of the most common types of cancer treated by oncologists. Treatment options for lung cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The lung cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of lung cancer, advances in treatment options, and the increasing availability of targeted therapies. The market is expected to continue to grow in the coming years due to the increasing demand for better treatments and the development of new therapies.
Some companies in the lung cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more